Yes, TB treatment can cause vaginal fungal infections (candidiasis)
The broad-spectrum antibiotics used in standard TB treatment—particularly rifampin—can precipitate vulvovaginal candidiasis by disrupting normal vaginal flora, and your patient's vaginal pruritus in the first month of treatment is likely antibiotic-induced candidiasis.
Why TB Treatment Causes Fungal Infections
The mechanism is well-established: antibiotics disrupt the normal bacterial flora that typically suppress Candida colonization. While approximately 10-20% of women normally harbor Candida species in the vagina asymptomatically 1, 2, antibiotic exposure triggers symptomatic overgrowth. Research demonstrates that antibiotic use increases the risk of symptomatic vaginal candidiasis 2.3-fold overall, with the highest risk in women aged 36-40 years (relative risk 6.0) 3. The attributable risk is particularly elevated with cephalosporins (12.8%), though rifampin and other TB medications have similar broad-spectrum effects 3.
TB treatment causes additional microbiome disruption beyond typical antibiotic courses. A 2017 study found that the 6-month multidrug TB regimen induces "profound dysbiosis of the microbiome that persists long after therapy is completed"—up to 1.2 years post-treatment 4. This prolonged disruption dramatically depletes immunologically significant commensal bacteria, creating an extended window of vulnerability for fungal overgrowth.
Diagnostic Approach for Your Patient
Confirm the diagnosis before treating:
- Clinical presentation: Pruritus with vulvovaginal erythema and possibly white discharge 1, 2
- Vaginal pH: Should be <4.5 (normal) for candidiasis 1, 2
- Wet mount with 10% KOH: Look for yeasts or pseudohyphae 1, 2
- Culture if microscopy negative: Confirms species and guides treatment 2
Critical pitfall: Do not treat Candida identified on culture in the absence of symptoms, as 10-20% of women are asymptomatic carriers 1, 2.
Treatment Recommendations
For uncomplicated vulvovaginal candidiasis (mild-to-moderate symptoms, first episode):
First-line options 2, 5:
- Fluconazole 150 mg oral tablet, single dose (most convenient)
- OR topical azole intravaginally:
- Clotrimazole 1% cream 5g for 7-14 days
- Miconazole 2% cream 5g for 7 days
- Terconazole 0.4% cream 5g for 7 days
For severe symptoms:
- Fluconazole 150 mg every 72 hours for 2-3 doses 5
Important considerations:
Topical vs. oral therapy: Both achieve equivalent 80-90% cure rates 2, 5. Oral fluconazole offers convenience but has rare drug interactions with rifampin (though not contraindicated). Topical agents avoid systemic interactions but oil-based preparations may weaken latex condoms 2.
If symptoms persist or recur within 2 months: Return for re-evaluation—do not self-treat repeatedly 2. Consider non-albicans species (particularly C. glabrata, which occurs in 10-20% of recurrent cases and responds poorly to azoles) 5.
For C. glabrata infection unresponsive to azoles 5:
- Boric acid 600 mg intravaginal gelatin capsule daily for 14 days
- OR nystatin 100,000-unit vaginal suppository daily for 14 days
- OR topical 17% flucytosine cream ± 3% amphotericin B cream for 14 days
Ongoing Management During TB Treatment
Expect potential recurrence: The prolonged microbiome disruption from TB treatment 4 means your patient remains at elevated risk for recurrent candidiasis throughout the 6-month TB regimen and potentially beyond.
For recurrent vulvovaginal candidiasis (≥4 episodes/year) 5:
- Initial therapy: 10-14 days of topical azole OR oral fluconazole
- Maintenance: Fluconazole 150 mg weekly for 6 months
Do not discontinue TB treatment: Continue the full TB regimen as prescribed. Candidiasis is manageable and does not require modification of tuberculosis therapy.
Partner treatment is generally not indicated for candidiasis, as it is not sexually transmitted 2. However, male partners with symptomatic balanitis may benefit from topical antifungal treatment.
Key Pitfalls to Avoid
Do not assume all vaginal symptoms are candidiasis: Bacterial vaginosis and trichomoniasis can coexist or present similarly. Confirm diagnosis with pH testing and microscopy 1, 2.
Do not treat asymptomatic colonization: Positive cultures without symptoms do not warrant treatment 1, 2.
Do not encourage repeated self-treatment with OTC preparations: This delays diagnosis of other conditions and can lead to inappropriate azole exposure 2.
Do not confuse this with systemic fungal infections: The question references fungal infections that can mimic TB (histoplasmosis, aspergillosis, etc.) 6, but these are distinct from antibiotic-induced vulvovaginal candidiasis.